Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12134654 Multispecific molecules and uses thereof

Patent 12134654 was granted and assigned to Marengo Therapeutics on November, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Marengo Therapeutics

0

Current Assignee

Marengo Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Stephanie J. Maiocco0

Brian Edward Vash0

Andreas Loew0

Date of Patent

November 5, 2024

0

Patent Application Number

166059360

Date Filed

April 19, 2018

0

Patent Citations

US Patent 8552156 Anti-TIM-3 antibody

0

US Patent 8609089 Compositions of PD-1 antagonists and methods of use

0

US Patent 9522196 Antibody recognizing folate receptors α and β

0

US Patent 9068002 Treatment of multiple sclerosis and/or rheumatoid arthritis

0

US Patent 7476724 Humanized anti-cmet antibodies

0

US Patent 7501121 IL-13 binding agents

0

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

0

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

0

...

Patent Primary Examiner

Meera Natarajan

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

Multispecific molecules targeting tumor associated macrophages (TAMs) or myeloid derived suppressor cells (MDSCs) and methods of using the same, are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12134654 Multispecific molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool